Vascular-specific growth factors and blood vessel formation
George D. Yancopoulos(Regeneron (United States)), Jocelyn Holash(Regeneron (United States)), Samuel Davis(Regeneron (United States)), Nicholas W. Gale(Regeneron (United States)), Stanley J. Wiegand(Regeneron (United States)), John S. Rudge(Regeneron (United States))
Cited by 3,682
Related Papers
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
|New England Journal of Medicine|2016|2k
VEGF-Trap: A VEGF blocker with potent antitumor effects
|Proceedings of the National Academy of Sciences|2002|1.7k
Regulation of the Germinal Center Response by MicroRNA-155
|Science|2007|1.5k
Angiopoietin-1 protects the adult vasculature against plasma leakage
|Nature Medicine|2000|1.3k
Evinacumab for Homozygous Familial Hypercholesterolemia
|New England Journal of Medicine|2020|763